Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

Overview of attention for article published in Journal of Translational Medicine, October 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 5 X users

patent: 2 patents

Readers on

mendeley: 75 Mendeley

Summary X Patents

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 4,097 followers.

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial. https://t.co/4rvs5YcmzV

14 Aug 2020

Reply Repost Favourite

RT @ctSEQ_papers: PubMed_ Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational explo…

03 Oct 2019

Reply Repost Favourite

RT @ctSEQ_papers: PubMed_ Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational explo…

03 Oct 2019

Reply Repost Favourite

PubMed_ Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial. https://t.co/vTP5zlDYIn

02 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.